Perrigo (PRGO) EBITDA (2012 - 2026)
Perrigo (PRGO) reported EBITDA of -$372.3 million for Q1 2026, down 893.82% year-over-year from $46.9 million in Q1 2025, and up 71.07% quarter-over-quarter from -$1.3 billion in Q4 2025.
Perrigo (PRGO) EBITDA (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has 15 years of EBITDA data on file, last reported at -$372.3 million in Q1 2026.
- EBITDA for Q1 2026 came in at -$372.3 million, down 893.82% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.5 billion (down 816.93% YoY), and the FY2025 annual result was -$1.1 billion, down 1093.98% from the prior year.
- EBITDA advanced to -$372.3 million in Q1 2026 per PRGO's latest filing, from -$1.3 billion in the prior quarter.
- Over five years, EBITDA peaked at $114.2 million in Q4 2024 and troughed at -$1.3 billion in Q4 2025.
- A 5-year average of -$67.7 million and a median of $33.1 million in 2022 frame the typical range for EBITDA.
- The sharpest annual moves came in 2023 and 2025: EBITDA jumped 923.19% in 2023, then tumbled 1227.06% in 2025.
- A 5-year view of EBITDA shows it stood at $31.0 million in 2022, then sank by 150.32% to -$15.6 million in 2023, then soared by 832.05% to $114.2 million in 2024, then plunged by 1227.06% to -$1.3 billion in 2025, then surged by 71.07% to -$372.3 million in 2026.
- Business Quant data shows PRGO's EBITDA at -$372.3 million in Q1 2026, -$1.3 billion in Q4 2025, and $72.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -681,231.97 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 185.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -67.29 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 81.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -98.81 Mn |
| 10 | Perrigo | 1.61 Bn | 1.25 Bn | 325.50 Mn | -372.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -372.30 Mn |
| Dec 31, 2025 | -1.29 Bn |
| Sep 27, 2025 | 72.60 Mn |
| Jun 28, 2025 | 45.40 Mn |
| Mar 29, 2025 | 46.90 Mn |
| Dec 31, 2024 | 114.20 Mn |
| Sep 28, 2024 | 80.40 Mn |
| Jun 29, 2024 | -26.50 Mn |
| Mar 30, 2024 | -55.20 Mn |
| Dec 31, 2023 | -15.60 Mn |
| Sep 30, 2023 | 62.10 Mn |
| Jul 1, 2023 | 56.80 Mn |
| Apr 1, 2023 | 48.50 Mn |
| Dec 31, 2022 | 31.00 Mn |
| Oct 1, 2022 | 33.10 Mn |
| Jul 2, 2022 | -6.90 Mn |
| Apr 2, 2022 | 21.70 Mn |
| Dec 31, 2021 | 46.70 Mn |
| Oct 2, 2021 | 438.30 Mn |
| Jul 3, 2021 | -125.90 Mn |